238 related articles for article (PubMed ID: 8971301)
1. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
Malaty H; el-Zimaity HM; Genta RM; Cole RA; Graham DY
Aliment Pharmacol Ther; 1996 Dec; 10(6):1001-4. PubMed ID: 8971301
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.
Cammarota G; Tursi A; Papa A; Montalto M; Veneto G; Cuoco L; Fedeli G; Gasbarrini G
Aliment Pharmacol Ther; 1996 Dec; 10(6):997-1000. PubMed ID: 8971300
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
6. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
Kato M; Asaka M; Kudo M; Sukegawa M; Katagiri M; Koshiyama T; Kagaya H; Nishikawa K; Hokari K; Takeda H; Sugiyama T
Aliment Pharmacol Ther; 1996 Oct; 10(5):821-7. PubMed ID: 8899093
[TBL] [Abstract][Full Text] [Related]
7. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N
Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
[TBL] [Abstract][Full Text] [Related]
8. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G
Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Ahuja V; Dhar A; Bal C; Sharma MP
Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
[TBL] [Abstract][Full Text] [Related]
10. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Inaba T; Mizuno M; Kawai K; Yokota K; Oguma K; Miyoshi M; Take S; Okada H; Tsuji T
J Gastroenterol Hepatol; 2002 Jul; 17(7):748-53. PubMed ID: 12121503
[TBL] [Abstract][Full Text] [Related]
11. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
[TBL] [Abstract][Full Text] [Related]
14. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
15. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
Di Mario F; Battaglia F; Dal Bò N; Leandro G; Benedetti E; Bottona E; Caroli A; Costan-Biedo F; De Bastiani R; Germanà B; Andrea Grassi S; Madia D; Marcon V; Marin R; Monica F; Olivieri P; Orzes N; Pilotto A; Ronzani G; Saggioro A; Tafner G
Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783
[TBL] [Abstract][Full Text] [Related]
16. Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients.
Labenz J; Beker JA; Dekker CP; Farley A; Klör HU; Jönsson A
Aliment Pharmacol Ther; 1997 Jun; 11(3):515-22. PubMed ID: 9218075
[TBL] [Abstract][Full Text] [Related]
17. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.
Vcev A; Stimac D; Ivandić A; Vceva A; Takac B; Pezerović D
Aliment Pharmacol Ther; 2000 Jan; 14(1):69-72. PubMed ID: 10632647
[TBL] [Abstract][Full Text] [Related]
18. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.
Dore MP; Piana A; Carta M; Atzei A; Are BM; Mura I; Massarelli G; Maida A; Sepulveda AR; Graham DY; Realdi G
Aliment Pharmacol Ther; 1998 Jul; 12(7):635-9. PubMed ID: 9701526
[TBL] [Abstract][Full Text] [Related]
19. Lansoprazole and amoxycillin: observations on the treatment of Helicobacter pylori infection.
Hazell SL; Daskalopoulous G; Mitchell HM; Massey D
J Gastroenterol Hepatol; 1997 Feb; 12(2):93-9. PubMed ID: 9083908
[TBL] [Abstract][Full Text] [Related]
20. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
Kashimura H; Suzuki K; Hassan M; Ikezawa K; Sawahata T; Watanabe T; Nakahara A; Mutoh H; Tanaka N
Aliment Pharmacol Ther; 1999 Apr; 13(4):483-7. PubMed ID: 10215732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
